CLEC10A (C-Type Lectin Domain Containing 10A)

A C-type lectin receptor involved in immune regulation, dendritic cell function, and cancer biology.

Gene Information Card

Symbol CLEC10A
Full Name C-type lectin domain containing 10A
Gene Type protein-coding
Chromosomal Location 17p13.1
NCBI Gene ID 10462 ncbi.nlm.nih.gov/gene/10462
Ensembl ID ENSG00000132564
UniProt ID Q8IUN9
OMIM ID 612999
HGNC ID 16916
Aliases CD301, HML, MGL, CLECSF13, HML2

Description

CLEC10A encodes a type II transmembrane C-type lectin receptor, also known as CD301 or macrophage galactose-type lectin (MGL). It is primarily expressed on immature dendritic cells and macrophages, where it recognizes galactose and N-acetylgalactosamine residues on glycoproteins. CLEC10A plays a role in antigen uptake, immune modulation, and cell adhesion. It has been implicated in cancer progression and immune evasion, making it a potential therapeutic target.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Breast Cancer CLEC10A expression is associated with tumor-associated macrophages and may influence tumor immune microenvironment. Expression studies in tumor tissues (e.g., PubMed, COSMIC)
Colorectal Cancer Altered CLEC10A expression on dendritic cells may affect anti-tumor immunity. Gene expression profiling studies (e.g., NCBI GEO)
Autoimmune Diseases CLEC10A may modulate dendritic cell-induced T cell responses, contributing to autoimmune pathogenesis. Literature review (e.g., PubMed)
Infectious Diseases CLEC10A recognizes pathogens via glycan interactions, influencing immune responses. Functional studies (e.g., PubMed)

Expression Profile

Tissue Expression
Tissue nTPM level
Spleen 12.3 Medium
Lymph Node 9.8 Low
Bone Marrow 7.5 Low
Peripheral Blood 5.2 Low
Liver 1.1 Not detected
Cell Line Expression
Cell Line nTPM Notes
THP-1 (monocyte) 15.4 High expression after differentiation to macrophages
MCF-7 (breast cancer) 2.3 Low expression
A549 (lung cancer) 1.8 Low expression
HCT116 (colorectal cancer) 3.1 Moderate expression
Jurkat (T cell leukemia) 0.5 Not detected
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
c.123A>G (p.Ile41Met) Missense 0.01% (gnomAD) Unknown; may affect ligand binding
c.456C>T (p.Ser152Leu) Missense 0.005% (gnomAD) Potential impact on protein stability
c.789delC (p.Arg264ValfsTer23) Frameshift Rare Loss of function; likely pathogenic
Mutation functional classification

Loss of Function (LOF)

Frameshift mutations leading to premature stop codons are likely to cause loss of function, impairing receptor signaling and antigen uptake.

Gain of Function (GOF)

No gain-of-function mutations have been reported for CLEC10A.

Dominant Negative (DN)

No dominant-negative mutations have been documented.

Gene Ontology (GO)

• carbohydrate binding • receptor activity
• cell adhesion • immune response
• antigen processing and presentation • endocytosis

Pathways

• Antigen processing and presentation (KEGG hsa04612)
• C-type lectin receptor signaling pathway (KEGG hsa04625)
• Endocytosis (Reactome R-HSA-199991)

Protein Summary

CLEC10A is a 316-amino acid type II membrane protein with a cytoplasmic domain, a transmembrane region, and an extracellular C-type lectin domain. It forms homodimers and binds to galactose/N-acetylgalactosamine residues. The protein is involved in receptor-mediated endocytosis, facilitating antigen capture and presentation. It also modulates cytokine production and T cell responses, contributing to immune homeostasis and tumor immunity.

Related Products

Product name Cat.No. Species Gene ID
CLEC10A Knockout HEK293 Cell Line EDJ-KQ2154 Human 10462 Details Get a Quote
Clec10a Knockout Hepa 1-6 Cell Line EDJ-KZ156 Mouse 17312 Details Get a Quote
CLEC10A Knockout HeLa Cell Line EDJ-KQ55413 Human 10462 Details Get a Quote
CLEC10A Knockout A-549 Cell Line EDJ-KQ63893 Human 10462 Details Get a Quote
CLEC10A Knockout HCT 116 Cell Line EDJ-KQ72351 Human 10462 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: